RLAY Relay Therapeutics Inc
Company Analysis
Latest News
🔴 Relay Therapeutics Inc is trading 4.4% down today amid a broad selloff in high-growth, rate-sensitive names
Relay Therapeutics Inc is trading at $12.93 (4.4% down) in after-hours trading, extending a sharp two-day slide seen during the regular session. • The stock...
🔴 Relay Therapeutics Inc is trading 10.5% down today as hot jobs report fuels growth-stock selloff
Relay Therapeutics Inc is trading 10.5% down at $13.02 as investors dump high-growth, rate-sensitive names following a stronger-than-expected U.S. jobs report...
🔴 Relay Therapeutics Inc is trading 5.1% down today on hot jobs report and rate jitters
Relay Therapeutics Inc is trading 5.1% down at $13.80 as a hotter-than-expected U.S. jobs report fuels concerns over rising interest rates and impacts...
🔴 Relay Therapeutics Inc is trading 4.9% down today on rate concerns and broader biotech selling
Relay Therapeutics Inc is trading 4.9% down at $13.84 amid broader risk-off pressure in growth and biotech names following a stronger-than-expected jobs...
🔴 Relay Therapeutics Inc is trading 4.05% down today, giving back gains from a recent rally
Relay Therapeutics Inc is trading 4.05% down today at $14.68, giving back a portion of its sharp gains from June 2, 2026. • No fresh company-specific news,...
🟢 Relay Therapeutics Inc is trading 18.44% up
RLAY is trading at $16.89, up 18.44%.
Relay Therapeutics Zovegalisib Shows 60% Response Rate in Rare Vascular Disease
Relay Therapeutics announced initial Phase 2 ReInspire trial data for zovegalisib. The study targets PIK3CA-driven vascular anomalies, which are rare disorders...
🔴 Relay Therapeutics Inc is trading 3.7% down today on normal volatility
Relay Therapeutics Inc is trading 3.7% down at $13.53 today on normal volatility within recent trading ranges and quiet news flow. • No fresh company...